U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07749261) titled 'Gut Microbiota and Tryptophan Metabolites in Parkinson's Disease' on Aug. 01.
Brief Summary: Parkinson's disease is a progressive neurological disorder that can also affect the digestive system. Changes in gut microorganisms and tryptophan metabolites may be associated with Parkinson's disease, but these relationships are not fully understood. This exploratory observational study will compare gut microbial communities and targeted tryptophan metabolite profiles between 15 participants with Parkinson's disease and 15 healthy controls matched by sex, age, and body mass index.
Each participant will provide clinical and lifestyle inform...